Access cutting-edge sepsis treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.
Access sepsis specialists in Minneapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related sepsis treatment provided free
The long-term goal is to test the clinical efficacy of senolytic therapies to reduce progression to and severity of sepsis in older patients. The central hypothesis is that a threshold burden of SnCs predisposes to a SASP mediated dysfunctional response to PAMPs, contributing to a disproportionate burden of sepsis in older patients. The study hypothesizes timely treatment with fisetin will interrupt this pathway. A multicenter, randomized, adaptive allocation clinical trial to identify the most
Sponsor: University of Minnesota
Check if you qualify for this sepsis clinical trial in Minneapolis, MN
If you're searching for sepsis treatment options in Minneapolis, MN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sepsis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.